Tetanus Immunoglobulin-VF (CSL) TM
You should seek medical advice in relation to medicines and use only as directed by a healthcare professional. Always read the label. If symptoms persist see your healthcare professional.
Active ingredients: tetanus immunoglobulin
Brand name
(ARTG)
: CSL TETANUS IMMUNOGLOBULIN-VF (human) 250IU injection vialDownload the Consumer Medicine Information Leaflet
Download consumer medicine information leaflet (pdf) from the Therapeutic Goods Administration (TGA) website
What this medicine is used for
(ARTG)
Tetanus Immunoglobulin is indicated for the passive protection of individuals who have sustained a tetanus-prone wound and who have either not been actively immunised against tetanus or whose immunisation history is doubtful. It should also be given to the fully immunised patient with a tetanus-prone wound if more than 10 years have elapsed since the last dose of toxoid. In all the above instances, active immunisation with Tetanus Toxoid, Adsorbed or ADT vaccine should be commenced at the same time [in accordance with details specified in table 1 (Guide to tetanus prophylaxis in wound management) in Indication section of the approved product information provided as Attachment 1]. Although Tetanus Immunoglobulin and vaccine should be given at the same time, they should be administered in opposite limbs, using separate syringes.
How to use this medicine
(ARTG)
This medicine contains one component only.
Component :
- Injection, solution
- Intramuscular
- Colourless, clear to opalescent solution
Storage conditions
(ARTG)
- Store at 2 to 8 degrees Celsius
- Protect from Light
- Do not Freeze
- Refrigerate
- Shelf lifetime is 3 Years.
Do I need a prescription ?
(ARTG)
These medicine packs are available from a pharmacist and requires a prescription. It is
- 250IU x 1 pack
Reporting side effects
You can help ensure medicines are safe by reporting the side effects you experience.
You can report side effects to your doctor, or directly at www.tga.gov.au/reporting-problems
